3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
34
Ovarian Neoplasms
7
Neoplasm Metastasis
6
Endometrial Neoplasms
6
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms by Site
3
Breast Diseases
3
Advanced Breast Cancer
3
Small Cell Lung Carcinoma
2
Melanoma
2
Hereditary Sensory and Autonomic Neuropathies
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Unilateral Breast Neoplasms
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Recurrence
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Genital Neoplasms, Female
1
Genetic Diseases, Inborn
1
Fallopian Tube Neoplasms
1
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
1
Interventions
Carboplatin
5
Radiotherapy
4
Radiation
3
Radiotherapy, Conformal
2
Platinum
2
Pemetrexed
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Disulfides
2
Cisplatin
2
Bevacizumab
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
methoxyamine
1
lazertinib
1
durvalumab
1
capmatinib
1
Taxes
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Nivolumab
1
Metformin
1
Ipilimumab
1
Granulocyte Colony-Stimulating Factor
1
Gefitinib
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
Fulvestrant
×
30 days
×
Clear all
No trials found.